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Alternative Activation Is an Innate Response to Injury That
Requires CD4 T Cells to be Sustained during Chronic Infection1
P’ng Loke,2* Iain Gallagher,2† Meera G. Nair,3† Xingxing Zang,‡ Frank Brombacher,§
Markus Mohrs,¶ James P. Allison,‡ and Judith E. Allen4†
Alternatively activated macrophages (AAM) are found in abundance during chronic Th2 inflammatory responses to
metazoan parasites. Important roles for these macrophages are being defined, particularly in the context of Th2-mediated
pathology and fibrosis. However, a full understanding of the requirements for alternative activation, particularly at the
innate level, is lacking. We present evidence that alternative activation by the Th2 cytokines IL-4 and IL-13 is an innate and
rapid response to tissue injury that takes place even in the absence of an infectious agent. This early response does not
require CD4 Th2 cells because it occurred in RAG-deficient mice. However, class II-restricted CD4 T cell help is essential
to maintain AAM in response to infection, because AAM were absent in RAG-deficient and MHC class II-deficient, but
not B cell-deficient mice after chronic exposure to the nematode parasite, Brugia malayi. The absence of AAM was
associated with increased neutrophilia and reduced eosinophilia, suggesting that AAM are involved in the clearance of
neutrophils as well as the recruitment of eosinophils. Consistent with this hypothesis, AAM show enhanced phagocytosis
of apoptotic neutrophils, but not latex beads. Our data demonstrate that alternative activation by type 2 cytokines is an
innate response to injury that can occur in the absence of an adaptive response. However, analogous to classical activation
by microbial pathogens, Th2 cells are required for maintenance and full activation during the ongoing response to metazoan
parasites. The Journal of Immunology, 2007, 179: 3926 –3936.
I t is now well known that macrophages can be alternativelyactivated by the type 2 cytokines IL-4 and IL-13 (1). Al-though the in vivo properties of these alternatively activated
macrophages (AAM)5 remain ill defined, their prevalence in
chronic type 2 inflammatory conditions such as parasite infection
(2–7) and allergy (8–10) strongly suggests an important function
under type 2 conditions. The importance of AAM during parasitic
infection has been confirmed using mice in which the IL-4R is spe-
cifically deleted from macrophages, significantly altering the outcome
of infection with both protozoan and metazoan parasites (11, 12). It
has been suggested that these macrophages are involved in tissue re-
modeling and wound healing (13), and our own data strongly support
this (3). Furthermore, there is increasing evidence that AAM play a
role in tumorigenesis (14, 15), which has sometimes been compared
with wound healing gone wrong (16). However, the origin and life
cycle of these cells, as well as the cells and mediators that are nec-
essary for the induction and upkeep of AAM, have not been well
characterized beyond a requirement for type 2 cytokines.
This is in contrast to the type 1 proinflammatory pathway in
which the interplay between innate and adaptive immunity has
been a major focus of the immunology field for the past decade
(17, 18). The importance of macrophage or neutrophil activation
via the engagement of TLRs (19) or by the IFNs ( or ) (20)
during the early phase of an acute microbial infection is increasingly
well understood. Subsequent Th1 cell development promotes more
effective macrophage killing that is essential in the control of many
intracellular pathogens (21). We wished to investigate the require-
ments for macrophage activation in the context of infection with nem-
atode parasites, which typically induce potent type 2 responses.
Our previous studies have shown that infection of mice with the
filarial nematode, Brugia malayi, leads to the recruitment of large
numbers of AAM to the peritoneal cavity (2, 22). These macro-
phages have an IL-4-dependent phenotype that is sustained
throughout several weeks of infection. This includes the suppres-
sion of cellular proliferation in a contact-dependent manner (2) and
the expression of the molecules Ym1/Chi3l3, Fizz1/Relm-, and
arginase 1 (3, 23), which are now considered reliable markers of
alternative macrophage activation (1, 6, 7). We thus chose to use
this in vivo system to investigate alternative activation during both
the early and late stages of a type 2 immune response. Our findings
reveal that type 2-dependent alternative activation can occur very
early in the immune response, independent of the adaptive arm of
the immune system and independent of infection. However, main-
tenance of the full alternative macrophage activation phenotype
requires CD4 T cells. These studies suggest that analogous to
type 1 proinflammatory processes, alternative type 2 activation
needs to be considered both in terms of an early innate response
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and later adaptive immune response, with distinct mediators and
functions at each stage.
Materials and Methods
Animals
For all experiments, mice used were 6–12 wk old at the start of the ex-
periment. All mice were bred and maintained in accordance with the ani-
mal care and use regulations of either University of California, University
of Edinburgh, or Trudeau Institute. Breeding stocks of RAG1/ and MHC
class II/ mice (on the C57BL/6 background) as well as wild-type (WT)
C57BL/6 control mice were obtained from The Jackson Laboratory.
C57BL/6 IL-4/ were originally purchased from B&K Universal with
permission of the Institute of Genetics, University of Cologne. BALB/c
IL-4R-deficient mice (24) and C57BL/6  (25) and WT control mice
were bred in house. Both male and female mice were used with identical
FIGURE 1. Kinetic differences between surgery only (Sham) and parasite implantation (Imp). A, Time course of arginase 1 expression. Real-time
RT-PCR was used to determine arginase 1 expression in PEC over the course of implantation with B. malayi parasites as well as in control mice undergoing
surgery only. B, Time course of cellular recruitment. Total cell numbers recruited to the peritoneal cavity were determined over the course of the experiment
for mice implanted with B. malayi or those undergoing surgery alone. The y-axis changes from a log scale to linear scale at 1  107. C, Proliferative
suppression by PEC. PEC from implanted or surgery-only mice were cocultured with the EL-4 thymoma cell line. Proliferation was monitored by the uptake
of [3H]thymidine. D, Time course of IL-10 expression by real-time RT-PCR, as described above for arginase. For each time point, n  5 for the implant
group and n  4 for the surgery-only group. A significant difference between the two experimental groups at a particular time point is indicated by  (p 
0.05) or  (p  0.01).
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results. The 4get mice (C.129-Il4tm1Lky/J) were generated, as previously
described (26), and backcrossed to BALB/c for 10 generations.
Nematode implant and surgery
B. malayi adult parasites were obtained from infected gerbils purchased
from TRS Laboratories or maintained in house. Adult worms were re-
moved from the peritoneal cavity of gerbils and washed in RPMI 1640.
Under anesthesia, a small surgical incision is made through both the
skin and the peritoneal membrane of the mouse, and five live adult B.
malayi females are introduced in a volume of up to 1 ml. The incision
is closed with the use of a medical stapler. Animals undergo sham
surgery following the above steps, but with no parasites introduced.
After 3– 6 wk (or times indicated in the text), mice were euthanized by
cardiac puncture and peritoneal exudate cells (PEC) were harvested by
thorough washing of the peritoneal cavity with 15 ml of ice-cold RPMI
1640 medium. For thioglycolate-induced macrophages, mice were in-
jected with 4% thioglycolate for 48 –96 h before PEC were harvested.
Suppression assay
Peritoneal lavage cells were plated at 1 106 cells/ml. Following 2- to 3-h
adherence at 37°C, the nonadherent cells were removed, leaving a cell
population highly enriched for macrophages (routine 	85% F4/80). Ad-
herent PEC were cocultured in 96-well flat-bottom plates with EL-4 cells
(1  104 cells/well) for 48 h. A total of 1 Ci of [3H]TdR in 10 l of
complete medium was then added to each well. Plates were incubated
overnight before harvesting and counting using a liquid scintillation
FIGURE 2. Requirements for early expression of alternative activation marker genes. A, Early alternative activation is independent of the adaptive
immune response. Real-time RT-PCR analysis of PEC was performed on RAG-deficient mice or WT C57BL/6 control mice that have undergone
a surgical incision and staple closure of the peritoneum. B, Role of IL-4 in early alternative activation. Real-time RT-PCR analysis of PEC was
performed on IL-4-deficient mice or WT C57BL/6 control mice treated as above. C, IL-4R signaling is required for alternative activation in response
to injury. Real-time RT-PCR analysis of PEC was performed on IL-4R-deficient mice or WT BALB/c control mice treated as above. Error bars
represent SDs between 4 and 5 per group.
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counter (Micro 1450; Trilux). Triplicate or quadruplicate measurements
per sample were performed. Results were plotted as cpm.
Real-time PCR
Total RNA was isolated using either TRIzol (Invitrogen Life Technolo-
gies) or Tri reagent (Sigma-Aldrich), and cDNA was synthesized using
either Moloney murine leukemia virus reverse transcriptase (Stratagene) or
Superscript II (Invitrogen Life Technologies). Real-time PCR of the cDNA
was conducted using either the Roche LightCycler or a GeneAmp 5700
(Applied Biosystems). Serial dilutions of a positive control sample of
cDNA were used as a standard curve in each reaction. The level of each
gene was expressed as a ratio to the level of either actin or GAPDH to
control for differing levels of cDNA in each sample. The results are shown
as arbitrary units. The primers have been described previously (3).
FACS, cytospin analysis, and ELISA
For FACS analysis, cells (2–5  105) were preincubated with unlabeled
-CD16/32 (24G2), and then incubated with -F4/80 (Caltag Laboratories)
and anti-Ly6G (eBioscience). Cytocentrifuge preparations of 1  105 cells
were made using a Shandon Cytospin 3 (Thermo Shandon). Cytospins
were air dried, fixed in methanol, stained with GIEMSA (Sigma-Aldrich)
or Diff-Quik reagent (Dade Behring), and examined with a microscope for
differential cell counting. For analysis of PEC from 4get mice, adherent
cells were depleted by incubation in culture dishes in RPMI 1640 for 1 h
at 37°C and flow cytometry was performed, as previously described (27).
For splenocyte recall assays, 1  106 cells were stimulated with medium
alone or B. malayi Ag (5 g/ml). Following stimulation for 84 h, 100 l
of supernatant was removed for cytokine assays. The IL-13 concentration
was determined by capture ELISA using the Quantikine mouse IL-13 im-
munoassay kit (R&D Systems), according to the manufacturer’s
instructions.
Ag presentation and phagocytosis assays
Macrophages from the peritoneal cavity were purified by adherence in
24-well plates and incubated for 30 min at 37°C with FITC-labeled latex
beads (Sigma-Aldrich) or CFSE-labeled human apoptotic neutrophils pro-
vided by the Centre for Inflammation Research (University of Edinburgh).
The phagocytosis of beads/neutrophils was assessed by microscopic visu-
alization of the wells or by FACS.
Statistical analysis
Unless otherwise stated, data between groups were compared with two-
tailed unpaired Student’s t test using Prism 3.0 (GraphPad) with a normal-
ity test. Error bars always show variation between individual mice.
Results
Expression of arginase 1 occurs early in response to surgery,
but is sustained only in the parasite-implanted group
Our experimental model involves the surgical implant of nematode
parasites into the peritoneal cavity of mice through a small incision
in the peritoneal wall. We had previously noted that some of the
markers associated with alternative macrophage activation were
seen in the first 1–3 days in both implanted mice and control mice
that underwent the surgical procedure only (3). To further inves-
tigate this finding, we assessed whether arginase 1, a AAM
marker known to be associated with wound repair (28), displayed
a similar pattern in parasite-implanted and surgery-only mice. We
also compared cell recruitment in these two groups of mice to
assess whether cell recruitment patterns differed at these early time
points.
As seen previously with Ym1 and Fizz1 (3), arginase 1 mRNA
was transiently elevated in PEC in response to surgical trauma and
returned to baseline by 1 wk postsurgery. In contrast, animals with
implanted parasites exhibited elevated arginase levels throughout
the 3-wk course of the experiment (Fig. 1A). The total numbers of
cells recruited into the peritoneal cavity were similar between sur-
gery-only and parasite-implanted mice in the first 3 days, suggest-
ing that the early cell recruitment is driven as much by surgical
intervention as parasite presence (Fig. 1B). A breakdown of spe-
cific cell types indicated that the cell recruitment patterns were
statistically indistinguishable in the first 3 days, with the one ex-
ception that parasite implant led to an immediate increase in eo-
sinophils at 24 h (6.7
 3.0 105) that was less pronounced in the
surgery-only mice (0.7
 0.3 105). The presence of the parasite,
however, led to a further increase in total cell numbers that was
still rising at 3 wk when the experiment was terminated with par-
asites still present (Fig. 1B). As previously published, the sustained
cellular exudate was comprised of eosinophils, macrophages, and
lymphocytes, with macrophages representing 	70% of the total
cell composition (29). In contrast, by day 10, the cell numbers in
surgery-only mice had declined, but macrophages and lympho-
cytes remained somewhat elevated for the remainder of the exper-
iment (data not shown). Thus, the drop in arginase seen above was
not simply a reflection of the drop in macrophage numbers, sug-
gesting that either alternative activation is short-lived in this set-
ting or the alternatively activated cells are specifically taken up by
the wound itself. As noted previously by ourselves and others (29,
30), parasite implant led to an early rise in neutrophil numbers that
declined as eosinophil and macrophage numbers increased.
Another hallmark of our nematode-elicited macrophages has
been the ability to suppress cellular proliferation in coculture,
which is dependent on IL-4 in the C57BL/6 strain (2). We thus
incubated the PEC from implanted or surgery-only mice with the
EL-4 cell line, a rapidly dividing thymoma cell line (Fig. 1C). As
described previously, PEC from nematode-implanted mice block
proliferation completely by 1 wk postimplant, and this suppression
remains for many weeks (31). We see a similar pattern in this
study, but also demonstrate significant suppressive capacity in the
PEC from surgery-only mice at days 3, 5, and 7 postsurgery, which
is no longer evident 10 days after surgery. Our results are consis-
tent with a role for AAM in wound healing after physical trauma.
The proper progression of wound healing can only occur if the
initial inflammatory response is controlled (32–35), and this
would be consistent with the suppressive function of these mac-
rophages. Analysis of nematode-elicited macrophage cytokine
production by cytokine bead array has revealed that they pro-
duce abundant IL-10 and IL-6 (data not shown), cytokines con-
sistent with both anti-inflammatory and wound healing func-
tions. We therefore assessed mRNA profiles of PEC from
nematode-implanted mice and sham surgery mice to determine
whether the types and amounts of cytokines were similar. IL-10 (Fig.
1D) and IL-6 (data not shown) followed a similar profile as the al-
ternative marker arginase (Fig. 1A).
FIGURE 3. C57BL/6, but not BALB/c mice make reduced IL-13 in the
absence of IL-4. WT and IL-4-deficient mice were implanted with B. ma-
layi parasites for 3 wk. Splenocytes from naive (cont) or B. malayi-im-
planted mice (imp) were cultured in medium alone (), or restimulated
with B. malayi Ag (f) for 72 h, following which the supernatants were
recovered for IL-13 cytokine ELISA. Error bars show SD from groups of
four to five individual mice.
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Ym1, Fizz1, and arginase 1 up-regulation in response to surgery
occurs independently of T or B cells, but requires IL-4
and/or IL-13
The rapid elevation (1–3 days) and then decline (3–5 days) in Ym1,
Fizz1 (3), and arginase 1 (Fig. 1A) suggested that these proteins are
part of the innate response to surgical trauma. To ask whether these
responses could occur in the absence of adaptive immunity, we per-
formed the surgical procedure on RAG/ mice that lack both B and
T cells. Ym1, Fizz1, and arginase 1 mRNA were all elevated in re-
sponse to the surgical procedure, and there was no significant differ-
ence between WT and RAG/ mice (Fig. 2A). Thus, this early re-
sponse is entirely innate with no requirement for B or T cells. These
data also illustrated subtle differences in kinetics that we consistently
observe. Ym1 expression peaks at 24 h, whereas Fizz1 and arginase
1 are slightly delayed, with expression peaking at 72 h.
In parasite-implanted C57BL/6 mice, the expression of Ym1,
Fizz1, and arginase 1 is dependent on IL-4 (3, 23). So, we asked
whether the early innate expression of these proteins was also IL-4
dependent. IL-4-deficient mice and the WT C57BL/6 controls un-
derwent the surgical procedure, and Ym1, Fizz1, and arginase 1
mRNA levels were assessed in the PEC by real-time RT-PCR.
Fizz1 and arginase 1 expression were reduced, but not absent in
IL-4-deficient mice. In contrast, Ym1 expression did not require
IL-4 at these early time points because mRNA levels were iden-
tical in WT and IL-4-deficient mice (Fig. 2B).
Ym1, Fizz1, and arginase 1 expression has previously been
shown to be strictly dependent on IL-4 on the C57BL/6 back-
ground following a 3-wk implant with B. malayi (3, 23). However,
on the BALB/c background, an absence of IL-4 was insufficient to
prevent alternative activation, and the absence of both IL-4 and
FIGURE 4. Cell recruitment in mice undergoing surgery alone. Differ-
ential cell counts 106 are shown for naive mice (D0) and 24 h (D1), 72 h
(D3), and 5 days (D5) postsurgery. From top to bottom, cells are as follows:
monocytes/macrophages, f; lymphocytes, ; eosinophils, u; and neutro-
phils, p. There were four or five mice per group. The following differences
were statistically significant (p  0.03, Mann-Whitney U test with Bon-
ferroni correction): neutrophils and eosinophils were reduced in the IL-
4/ vs WT at day 3, whereas lymphocytes were increased. Neutrophils
and eosinophils were reduced in the IL-4R/ vs WT at days 1, 3, and 5.
Neutrophils were elevated in the RAG1/ vs WT at day 3, and lympho-
cytes were reduced at all days in the RAG1/ compared with the WT
mice. The WT data from all three experiments are shown in a single com-
bined graph, but statistics were calculated between gene-deficient and WT
mice for each individual experiment.
FIGURE 5. Identification of IL-4-
expressing cells in the peritoneal cavity
with the 4get mice. A, Representative
plots showing c-kit and anti-IgE stain-
ing to identify basophils (anti-IgE, c-
kit) and mast cells (anti-IgE, c-kit)
within the GFP population as well as
showing CD4 and CCR3 staining to
identify Th2 cells (CD4) and eosino-
phils (CCR3) that are GFP. B, Rel-
ative proportions of GFP cells in PEC
populations. C, Representative plots
showing changes in cellular popula-
tions postsurgery. Plots show forward
and side scatter, as well as Siglec F and
Ly6G/Gr1 staining to identify mature
eosinophils. D, Whisker plots showing
the range and median total number of
GFP Siglec F cells (eosinophils) and
GFP, c-Kit, and IgE (mast cells) in
either resident peritoneal cells or 72 h
after surgery.
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IL-13 signaling was required (our unpublished observation). We
hypothesized that in the absence of IL-4, C57BL/6 mice fail to
develop Th2 cells that produce IL-13, but in the more Th2-prone
BALB/c mouse, IL-13 may still be produced. To address this, we
measured IL-13 production by splenocytes from naive and im-
planted WT and IL-4-deficient mice on both C57BL/6 and
BALB/c backgrounds. Indeed, we found that IL-4-deficient mice
on the BALB/c background make considerable amounts of IL-13
in response to B. malayi implant, whereas on the C57BL/6 back-
ground little IL-13 is produced in the absence of IL-4 (Fig. 3).
These data suggested that in vivo IL-13 may have an equal or
greater role to play than IL-4 in the induction of Ym1 and Fizz1.
We thus chose to use the IL-4R-deficient mice to assess whether
the inability of IL-4 to affect Ym1 expression during the early
injury response could be explained by the presence of IL-13. These
experiments were performed on the BALB/c background because
this was the only strain available to us. We found that indeed in the
absence of IL-4R signaling, there was a near complete ablation of
Ym1 expression relative to BALB/c controls, whereas Fizz1 and
arginase 1 were entirely absent (Fig. 2C). Thus, the IL-4R/
mice demonstrate that innate expression of Ym1, Fizz1, and argi-
nase 1 requires either IL-4 or IL-13. Different target cells for IL-4
vs IL-13 may explain the subtle differences in expression kinetics
for these alternative activation markers.
Thus, the cells recruited to injury had the hallmarks of alterna-
tively activated cells, because they expressed Ym1, Fizz1, and
arginase 1, and blocked the proliferation of bystander cells. Fur-
thermore, expression of the alternative activation markers was
strictly dependent on the Th2 cytokines IL-4 and IL-13. We ana-
lyzed the cell types present in the peritoneal cavity in the first 5
days following surgery in these gene-deficient mice. In the control
WT mice, neutrophils and macrophages represented the dominant
cell types at day 1 and peaked by day 3 (Fig. 4). Macrophage
numbers continued to rise and exceeded the neutrophil numbers by
day 5. With the exception of a complete absence of lymphocytes,
RAG/ mice showed near identical recruitment patterns to the
WT mice at these early time points, whereas in the IL-4/ and
IL-4R/ mice, granulocyte numbers (both eosinophils and neu-
trophils) were reduced relative to WT (Fig. 4).
To determine the potential source of early IL-4, we utlilized the
4get mice that express GFP as part of a bicistronic IL-4 internal
ribosomal entry site (IRES)-GFP mRNA (26). GFP cells are rare
in naive mice (26) and reflect cells expressing IL-4 transcript.
Flow cytometric analysis of GFP cells with markers for ba-
sophils, mast cells, eosinophils, and T cells (27, 36) allowed us
to delineate which cells in the peritoneal cavity of naive mice have
the capacity to produce IL-4. The composition of the GFP cells was
50% eosinophils and 40% mast cells (Fig. 5, A and B). Ten percent
were Th2 cells, but these are not a possible source of early IL-4 in the
RAG/ experiments. In addition, we assessed the GFP cells after
surgery and found that the mast cell population was dramatically re-
duced, consistent with our previous cytospin analyses, and that now
eosinophils represented 	90% of the cells positive for IL-4 mRNA.
Sustained presence of AAM during nematode infection
requires the adaptive immune response
Because our surgery experiments demonstrated the absence of a re-
quirement for the adaptive immune system in the generation of the
alternatively activated phenotype, we chose to examine whether the
sustained activation of macrophages we see during nematode infec-
tion could also occur independently of adaptive immunity. To test
this, we implanted B. malayi into the peritoneal cavities of RAG1/
mice for 3 wk. Control RAG1/ mice injected with thioglycolate
recruited equal numbers of peritoneal cells (Fig. 6A), with similar
percentages of F4/80 macrophages (data not shown) as WT mice,
indicating that there is no inherent macrophage recruitment defect in
RAG1/ mice. In contrast, there was a dramatic difference in the
number of cells recruited by the parasites in WT vs RAG1/ mice
(Fig. 6A). Although peritoneal cells in RAG1/ naive mice in-
creased from 5 105 cells per mouse (compared with 2.5 106 cells
in WT mice), to a mean of 1.55  106 (
4.4  105) cells after
infection. This was much less than the mean of 1.63  107 (
3.8 
106) cells recruited in WT mice.
To determine whether the inflammatory cells recruited in
RAG1/ mice contain AAM, we looked by real-time PCR for
FIGURE 6. Alternative activation by B. malayi requires adaptive im-
munity to be sustained and is absent in RAG1-deficient mice. A, Parasite-
implanted C57BL/6 or RAG1/ mice were compared with mice either
injected with 4% thioglycolate or left naive (data not shown). The PEC
were counted on a Coulter counter. Data shown are compiled from five
experiments with parasites and three experiments with thioglycolate, and
are indicated by separate symbols being used for separate experiments. B,
Expression of AAM marker genes Ym1, Fizz1, and arginase 1 was de-
termined by real-time RT-PCR analysis of total PEC. Data shown are a
representative of five separate experiments with identical results. The error
bars show the SD between individual mice (n  3 for WT imp, and n 
5 for RAG1/ imp for this experiment). , p  0.0005.
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the expression of Ym1, Fizz1, and arginase 1. Although cell re-
cruitment was very low in RAG1/ mice, sufficient cells were
present for mRNA analysis. Cells isolated from RAG1/ mice
did not display significant expression of Ym1, Fizz1, or arginase 1
(Fig. 6B) and were similar to thioglycolate controls (data not
shown). Analysis of adherent cells enriched further for macro-
phages showed similar results (data not shown). These results sug-
gest that either B or T cells are required for a sustained presence
of AAM. Of note, inducible NO synthase was elevated in the
implanted RAG/ mice, suggesting that the small numbers of
cells recruited were in a classical activation state.
CD4 T cells, but not B cells, are required to maintain AAM
during an adaptive immune response
We predicted that CD4 T cells were the most likely component
of adaptive immunity that would be required for AAM recruit-
ment. Hence, we implanted parasites into mice lacking class II
FIGURE 7. Recruitment of AAM requires CD4 T cells, but not B
cells. A, B. malayi parasites were implanted into MHC class II-deficient
mice and C57BL/6 mice, as above, and were compared with thiogly-
colate injection. The numbers of PEC were counted using a Coulter
counter. Data shown are compiled from three experiments with para-
sites and two experiments with thioglycolate, and are indicated by sep-
arate symbols being used for separate experiments. B, The total number
of F4/80 macrophages was determined by FACS. Data shown are a
representative of three separate experiments. C, MHC class II deficient
mice do not recruit AAM after B. malayi implantation. This graph is
plotted on a log scale. Data shown are a representative of three separate
experiments with identical results. Error bars represent SDs between
individual mice (n  3 for WT imp and n  5 for MHC/ imp for
this particular experiment). D, B cell deficient MT mice recruit
AAM after B. malayi implantation. Expression of the marker genes
Ym1 and Fizz1 in adherent macrophage (	80% F4/80) populations
was determined by real time PCR analysis as described above. Data
shown are a representative of three separate experiments with identical
results. Error bars represent SDs between individual mice (n  3 for
WT imp and n  5 for MT imp for this particular experiment).
, p  0.0005.
FIGURE 8. Increased neutrophilia and decreased eosinophilia in B. ma-
layi-implanted MHC class II-deficient mice. A, Example of the cellular com-
position of PEC from parasite-implanted C57BL/6 (WT) mice and MHC II/
mice. Eosinophils (Eos) and neutrophils (Neu) are indicated with arrows. B,
Representative FACS analysis of PEC showing the proportion of F4/80mac-
rophages and Ly6G (Gr1) neutrophils. C, The proportion of eosinophils from
implanted mice was determined by counting 	300 cells from randomly se-
lected fields per Giemsa-stained cytospin. Data are compiled from three sep-
arate experiments indicated by separate symbols. The proportion of neutrophils
was determined by FACS, as described above. Data are compiled from two
separate experiments.
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MHC (MHC II/), which are defective in selecting for CD4 T
cells (37) and are a better model for T cell help than CD4-deficient
mice, in which the CD8 population is heavily contaminated with
MHC class II-restricted T cells (38). There was a striking reduction
in the number of total cells recruited after implantation of MHC
II/ mice (Fig. 7A). There were also fewer F4/80 macrophages
recruited in these mice (Fig. 7B), consistent with our previous
study of nude mice (22). Thioglycolate-injected MHC II/ mice
recruited similar numbers of macrophages and PEC as WT mice
(Fig. 7A). Expression of Ym1 and Fizz1 mRNA was reduced to
control levels in parasite-implanted MHC II / mice (Fig. 7C).
Thus, class II-restricted T cell help is apparently required for the
sustained recruitment and differentiation of AAM in vivo.
Because RAG1/ mice lack both B and T cells, we chose to
also assess whether B cells are an important component of the
adaptive response required for AAM differentiation and mainte-
nance. We therefore implanted parasites into B cell-deficient MT
mice and looked for the expression of AAM marker genes. In
contrast to the analysis of RAG1/ and MHC II / mice, iden-
tical numbers of peritoneal cells, including F4/80 macrophages,
were recruited in MT mice (data not shown), which expressed
comparable levels of AAM genes as WT mice after parasite
implantation (Fig. 7D).
AAM induced during an adaptive immune response may
mediate clearance of early neutrophilia
To determine whether there were any changes in the composition
of cell types in MHC II/ mice, we compared the inflammatory
PEC by FACS and cytospin analysis. We observed an increase in
neutrophils and a marked decrease in eosinophils (Fig. 8). The
reduction of eosinophils was not surprising and is consistent with
the known role of Th2 cytokines in eosinophil development and
recruitment (39). Ramalingam et al. (30) have also shown that
CD4 cells play a role in recruiting eosinophils in the closely
related Brugia pahangi infection model. However, the increase in
neutrophilia was unexpected. Parasite-implanted RAG/ mice
also had elevated neutrophils similar to MHC II/ mice (data not
shown). The sustained presence of neutrophils in mice lacking
AAM suggested that AAM might also play a role in the clear-
ance of neutrophils. Hence, we used an in vitro system to deter-
mine whether AAM could phagocytose neutrophils. We found
that AAM from parasite-implanted WT mice were significantly
better at phagocytosing neutrophils than thioglycolate-induced
macrophages (Fig. 9). In contrast, there was no difference in their
ability to phagocytose latex beads (Fig. 9). Macrophages from
C57BL/6 IL-4/ mice were as capable as macrophages from WT
mice at phagocytosing neutrophils. This is consistent with the fact
that we did not observe an increase in neutrophilia in C57BL/6
IL-4/ mice, even though macrophages from these mice do not
possess the markers of alternative macrophage activation (2, 3, 23,
31) These data suggest that macrophages in the nematode infection
setting are influenced by factors other than IL-4 alone.
Discussion
We have used a surgical implant model of filarial nematode par-
asite infection to illustrate the requirements for both innate and
adaptive cells for alternative activation during acute vs chronic
inflammatory responses. These studies reveal that there is an innate
alternative activation pathway that does not require adaptive im-
munity and can be triggered solely by tissue injury. Although ac-
tivation of innate cells by microbial products or proinflammatory
cytokines has long been documented, activation by early sources
of Th2 cytokines or Th2-inducing pathogen products remains ill
defined. Metazoan parasites are well known to induce early and
rapid IL-4 (40–43), and there is also evidence that their secreted
products can lead to alternate macrophage activation (29, 44).
However, we show in this study, the markers of alternative acti-
vation could be induced in the absence of parasite products and can
occur in response to a tissue injury, without the presence of T cells.
The IL-4R/ mice demonstrated that innate expression of Ym1,
Fizz1, and arginase 1 requires either IL-4 or IL-13, as previously
reported for allergy, fibrosis, and infection (45–48).
The innate source of IL-4 or IL-13 triggering this injury re-
sponse has yet to be identified, but is likely to be eosinophils or
mast cells. Analysis of 4get mice revealed that eosinophils, mast
cells, and Th2 cells were the only populations in the peritoneal
cavity of naive mice expressing IL-4 mRNA. Very few basophils
were present. T cells can be excluded because we observed the
IL-4R-dependent injury response in RAG-deficient mice. Fol-
lowing surgery, there was a dramatic increase in the numbers of
IL-4 eosinophils accompanied by a drop in mast cell numbers.
Eosinophils have been previously identified as innate IL-4-produc-
ing cells in Nippostrongylus brasiliensis (49), Schistosoma man-
soni (42), and Heligomosoides polygyrus infection (36). Although
these data implicate eosinophils as the trigger for alternative acti-
vation, mast cells cannot be ruled out. Mast cells are considered
sentinels of tissue injury (50) and are known to rapidly produce
IL-4 or IL-13 (27, 51). The rapid decline in mast cells following
surgery may reflect degranulation or activation-induced adherence
to the peritoneal wall with release of cytokine stores.
Recently, Reece et al. (52), using the N. brasiliensis model,
demonstrated innate expression of ym1, fizz1, and arg1 in the lungs
of infected SCID mice. Because N. brasiliensis migration leads to
severe lung damage, the study supports a role for these proteins as
responders to tissue injury. However, it is not possible to deter-
mine whether the response was the result of tissue damage or hel-
minth Ags. Our study demonstrates that an innate type 2 response
will occur solely in response to physical trauma. An intriguing
twist to this story is the recent discovery that chitin, a molecule
found in many pathogens and allergens, but not in mammals, leads
FIGURE 9. Thioglycolate-recruited macrophages (Thio) or parasite-re-
cruited macrophages (Imp) were incubated with FITC-labeled latex beads
or apoptotic neutrophils. The percentage of macrophages that had phago-
cytosed beads or neutrophils was determined by FACS. Data shown are
representative of three separate experiments. , p  0.01.
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to rapid alternative activation through recruitment of IL-4-express-
ing cells (53). Because chitin is unlikely to be found in our sterile
surgical procedure, it raises the possibility that endogenous acti-
vators of IL-4 include chitin-like sugars. Ym1 itself is a molecule
that can bind chitin, but also has the ability to bind an array of host
sugars (54). The finding that Ym1 is needed for Th2 cell activation
(55) suggests that it may play a role in triggering activation by
these sugars. This raises the question as to whether there are fun-
damental differences in alternative activation by endogenous li-
gands vs pathogen-derived molecules. We have found that the abil-
ity of some parasite-derived molecules to induce AAM (29) is
entirely dependent on IL-4 or IL-13 (our unpublished observation)
as is the innate wounding response described in this work. Thus,
the key factor seems to be the ability to induce IL-4 and/or IL-13.
Whether parasite and host factors are acting through distinct (and
thus potentially additive) pathways has yet to be determined. How-
ever, in our study, the sham surgery response was as great as that
seen with surgical parasite implant, suggesting that the wounding
response was dominant and the parasite at these early stages was
not augmenting this response.
The main difference between sham surgery and parasite implant
was the sustained Th2 cell-dependent response. With the knowl-
edge that alternatively activated macrophages are part of the innate
response, this raises an additional question about their role in Th2
cell induction. We have shown in vitro that macrophages from
Brugia-implanted mice can prime naive T cells to differentiate into
Th2 cells (56), and Ym1 has been shown to be an important DC
factor involved in Th2 differentiation (55). These data along with
the knowledge that inflammatory macrophages can traffic to the
draining lymph nodes to prime T cell responses (57) would support
a role for these macrophages in Th2 induction. However, we have
also shown that AAM, unlike T regulatory cells, do not become
detectable in the draining lymph nodes of filarial-infected mice
until the infection becomes systemic (58), arguing against a role in
early induction of Th2 cells. Regardless of whether the AAM
play a role in Th2 induction, the data do suggest they are involved
in orchestrating the sequence of events. We have previously found
that there is an early influx of neutrophils during the acute phase of
the response, but they are gradually replaced by eosinophils and
are essentially gone after 2 wk (29), and this pattern was observed
again in this study (data not shown). A recent study demonstrated
that AAM contribute significantly to eosinophil recruitment (59).
Put together with our finding that AAM may also mediate neu-
trophil clearance, a model is suggested whereby macrophages or-
chestrate the cell recruitment profile during type 2 inflammation,
through an initial clearance of neutrophils, followed by the recruit-
ment of eosinophils, with Th2 cells required for the second phase.
Whether they are also responsible for Th2 induction and whether
wound AAM vs parasite AAM differ in this regard still needs
to be addressed.
Our previous work points to AAM as the main source of
Fizz1, Ym1, and arginase 1 in the peritoneal population (3, 23).
However, neutrophils may be an important source of these proteins
at early time points because they have been shown to contain Ym1
(60) and are the predominant cell in WT and RAG/ mice in the
first 24–48 h (this study) (29), but are significantly reduced in the
IL-4R/ mice that failed to express AAM-associated markers.
Evidence also suggests that neutrophils can be classified into clas-
sical or alternative categories (61). Additionally, eosinophils were
significantly elevated at 1 and 3 days postsurgery and can express
both Fizz1 (49) and Ym1 (our unpublished observations). Al-
though arginase expression has been described in human granulo-
cytes, in mouse studies to date, Th2-inducible arginase has only
been described in macrophages (62). Differential expression of
Ym1 (peaking at day 1) as compared with Fizz 1 and arginase 1
(peaking at day 3) could suggest that different cell types are re-
sponsible for the early production of these proteins.
Although our data provide strong evidence for alternative acti-
vation as a part of the innate response to injury, the expression of
these markers was transient. Only in the presence of the helminth
parasite were macrophage numbers as well as AAM-associated
markers sustained. This required the adaptive immune response
because AAM were absent in the RAG/ mice at later time
points, contrasting directly with the injury response. Consistent
with this finding, expression of AAM markers during N. brasil-
iensis infection declines after 1 wk in SCID, but not WT mice (52).
Our results show that the component of the adaptive immune response
required to sustain alternative macrophage activation are class II-re-
stricted CD4 T cells with no requirement for B cells. Specifically,
because the expression of these genes is dependent on type 2 cyto-
kines, it is Th2 cells that are required. Interestingly, costimulation
through CD28 is not necessary for this component of CD4 T cell
function (63). This is consistent with the completely normal Th2 re-
sponse observed in CD28-deficient mice infected with a different
nematode parasite H. polygyrus (64). Additionally, we have shown
that despite a role in the induction of type 2 Abs, ICOS costimulation
is also not required for the AAM phenotype (63).
The observation that T cell help is required for alternative mac-
rophage activation is important because CD4 T cells are known
to be essential for the formation of immune granulomas, which
play a role in protecting both the host and the parasite (30, 65). In
the mouse schistosomiasis model, CD4 T cells have been shown
to play a role in granuloma formation through studies with MHC
class II-deficient mice and through anti-CD4 depletion experi-
ments (66, 67). More recently, macrophages expressing high levels
of arginase 1 have been implicated in the deposition of collagen
and formation of fibrotic granulomas (7). Our results suggest that
the recruitment of AAM could be a crucial mechanism through
which CD4 T cells are involved in fibrotic granuloma formation.
Our results would suggest that AAM could also be key interme-
diaries between CD4 Th2 cells in asthma and downstream effects
such as eosinophil recruitment (59) and tissue remodeling (through
arginase 1/Ym1) (10).
It is important to stress that although IL-4/IL-13-mediated re-
sponses may be important in tissue repair, they do not appear to be
essential. Although we have never directly quantified the rate of
wound repair in our surgery model, the incision is effectively
healed in the mice that lack IL-4 or IL-4R. Nonetheless, the im-
portance of type 2 cytokines in damaging tissue remodeling and
fibrosis is increasingly well documented (1, 68). It now becomes
important to ask the following: what is the role of type 2 cytokines
in normal repair, and why do helminth parasites induce an immune
response that has as a primary function wound healing? The an-
swer to the second question may lie with the propensity of many
parasites to induce potentially lethal tissue damage. Hookworm
parasites penetrate the gut wall to feed, whereas schistosome eggs
use proteolytic enzymes to enter the gut. Both situations could
potentially lead to sepsis, unless the repair of gut wall was rapid
and effective, thus providing sufficient evolutionary pressure for
the development of a worm-specific tissue repair process (69). In-
deed, S. mansoni infection of mice that lack AAM is fatal due to
endotoxemia (11), potentially explained by the inability of these
mice to repair a breach of the intestinal wall. Similarly, many
helminthic parasites have a migratory stage through the lung that
leads to substantial pulmonary hemorrhaging that is repaired re-
markably quickly (70).
We hypothesize that IL-4 and/or IL-13 may mediate a more
rapid form of tissue repair that is necessary to maintain tissue
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integrity. This may be at the expense of higher quality repair. Con-
sistent with this hypothesis, Eming et al. (71) demonstrated accel-
erated closure of skin punch biopsy wounds in IL-10-deficient
mice, but at the cost of biomechanical strength. Importantly, Ym1-
expressing macrophages were more abundant in the rapidly heal-
ing mice. The well-described anti-inflammatory properties of
AAM (1) are also consistent with a role for these cells in accel-
erating the rate of tissue repair, because effective healing cannot
progress until classical inflammation has ended (32–35). To test
these hypotheses, it will be necessary to develop or identify both
helminth and nonhelminth models in which the rate of repair is a
determining factor in outcome.
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